Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan

被引：0
|
作者：
Ohishi, Mitsuru [1 ]
Ito, Norihisa [1 ]
Takagi, Takashi [1 ]
Terai, Minako [1 ]
Tatara, Yuji [1 ]
Shiota, Atsushi [1 ]
Hayashi, Norihiro [1 ]
Katsuya, Tomohiro [1 ]
Rakugi, Hiromi [1 ]
Ogihara, Toshio [1 ]
机构：
[1] Osaka Univ, Sch Med, Suita, Osaka 565, Japan
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：364 / 364
页数：1
相关论文
共 50 条
  • [31] Effects of angiotensin II-Receptor blocker, valsartan, on residual renal function in patients on CAPD.
    Kikuta, T
    Watanabe, Y
    Kanno, Y
    Tomori, K
    Nakamoto, H
    Okada, H
    Suzuki, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 482A - 482A
  • [32] Angiotensin II type 1 receptor genotype and response to angiotensin II receptor blocker valsartan in early stage diabetic nephropathy
    Takei, Kako
    Kimura, Tomomi
    Miyazaki, Mitsuhiro
    Matsumoto, Ryuma
    muramatsu, Masaaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 223 - 223
  • [33] Candesartan, an angiotensin II receptor blocker, improves left ventricular hypertrophy and insulin resistance
    Anan, F
    Takahashi, N
    Ooie, T
    Hara, M
    Yoshimatsu, H
    Saikawa, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (06): : 777 - 781
  • [34] Palatability, efficacy and tolerability of the angiotensin II receptor blocker candesartan in children with hypertension or proteinuria
    Simonetti, G. D.
    Rizzi, M.
    von Vigier, R. O.
    Cortesi, C.
    Bianchetti, M. G.
    SWISS MEDICAL WEEKLY, 2007, 137 : 42S - 42S
  • [35] Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring
    Sica, Domenic
    White, William B.
    Weber, Michael A.
    Bakris, George L.
    Perez, Alfonso
    Cao, Charlie
    Handley, Alison
    Kupfer, Stuart
    JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (07): : 467 - 472
  • [36] Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function
    Seeger, H
    Lippert, C
    Wallwiener, D
    Mueck, AO
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (02) : 141 - 143
  • [37] Comparison of vasculoprotective effect of angiotensin receptor blocker, candesartan and diuretics in patients with essential hypertension
    Yamakado, M
    Ishizaka, Y
    Maehata, E
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 134A - 134A
  • [38] Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling
    Bhuiyan, Mohiuddin Ahmed
    Ishiguro, Masaji
    Hossain, Murad
    Nakamura, Takashi
    Ozaki, Masanobu
    Miura, Shin-ichiro
    Nagatomo, Takafumi
    LIFE SCIENCES, 2009, 85 (3-4) : 136 - 140
  • [39] Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan)
    Petramala, Luigi
    Letizia, Claudio
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (04) : 252 - 252
  • [40] Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan
    Clements, Richard T.
    Vang, Alexander
    Fernandez-Nicolas, Ana
    Kue, Nouaying R.
    Mancini, Thomas J.
    Morrison, Alan R.
    Mallem, Krishna
    McCullough, Danielle J.
    Choudhary, Gaurav
    CIRCULATION-HEART FAILURE, 2019, 12 (11)
12345